PLIN1
Perilipin-1
Also known as: PLIN, PLIN1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60240
- Gene
- PLIN1
- Ensembl
- ENSG00000166819
- Chromosome
- 15
- Canonical length
- 522 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Peroxisomes
OverviewNCBI Gene
The protein encoded by this gene coats lipid storage droplets in adipocytes, thereby protecting them until they can be broken down by hormone-sensitive lipase. The encoded protein is the major cAMP-dependent protein kinase substrate in adipocytes and, when unphosphorylated, may play a role in the inhibition of lipolysis. Alternatively spliced transcript variants varying in the 5' UTR, but encoding the same protein, have been found for this gene. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
522 residues, UniProt reviewed canonical sequence.
>O60240|PLIN1
1 MAVNKGLTLL DGDLPEQENV LQRVLQLPVV SGTCECFQKT YTSTKEAHPL VASVCNAYEK
61 GVQSASSLAA WSMEPVVRRL STQFTAANEL ACRGLDHLEE KIPALQYPPE KIASELKDTI
121 STRLRSARNS ISVPIASTSD KVLGAALAGC ELAWGVARDT AEFAANTRAG RLASGGADLA
181 LGSIEKVVEY LLPPDKEESA PAPGHQQAQK SPKAKPSLLS RVGALTNTLS RYTVQTMARA
241 LEQGHTVAMW IPGVVPLSSL AQWGASVAMQ AVSRRRSEVR VPWLHSLAAA QEEDHEDQTD
301 TEGEDTEEEE ELETEENKFS EVAALPGPRG LLGGVAHTLQ KTLQTTISAV TWAPAAVLGM
361 AGRVLHLTPA PAVSSTKGRA MSLSDALKGV TDNVVDTVVH YVPLPRLSLM EPESEFRDID
421 NPPAEVERRE AERRASGAPS AGPEPAPRLA QPRRSLRSAQ SPGAPPGPGL EDEVATPAAP
481 RPGFPAVPRE KPKRRVSDSF FRPSVMEPIL GRTHYSQLRK KSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLIN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 898 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 898 nTPM
- breast: 460 nTPM
- blood vessel: 95 nTPM
- liver: 41 nTPM
- salivary gland: 20 nTPM
- tongue: 16 nTPM
Single-cell type
- adipocytes: 880 nCPM
- hepatocytes: 79 nCPM
- astrocytes: 9.9 nCPM
- fibro-adipogenic progenitors: 8.1 nCPM
- cdc: 7.7 nCPM
- late spermatids: 7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 23 nTPM
- amygdala: 17 nTPM
- midbrain: 17 nTPM
- thalamus: 15 nTPM
- hypothalamus: 14 nTPM
- hippocampal formation: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PLIN1.
Disease | AllUniProt
Conditions PLIN1 is implicated in, by any mechanism.
- Lipodystrophy, familial partial, 4 (FPLD4) MIM:613877
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 195 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- PLIN1-related familial partial lipodystrophy
ReferencesPubMed · IEDB
Publications for PLIN1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.
2023 · Diabetes · RCR 3.9 · 38 citations - Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy.
2023 · Diabetes · RCR 3.5 · 29 citations - Autoantibodies Against Perilipin 1 as a Cause of Acquired Generalized Lipodystrophy.
2018 · Front Immunol · RCR 1.2 · 32 citations - Perilipin-1 autoantibodies are a robust marker of acquired lipodystrophy and may precede clinical detection.
2025 · Pediatr Allergy Immunol · 1 citations - Anti-perilipin-1 autoantibodies in autoimmune Addison's disease and related endocrine disorders.
2025 · Autoimmunity · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.93
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Perilipin
- Perilipin family
- Perilipin-1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLIN1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLIN1 as an antibody target. Whether an autoantibody or antibody against PLIN1 could matter depends on whether native PLIN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLIN1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLIN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...